IL32 and plasma cell myeloma: Our earlier study showed that an antagonist against HGF, that is, NK4, also inhibited HGF/c‐MET signaling and anti‐angiogenic activity in a mouse MM xenograft model, indicating the growth dependency of myeloma cells on HGF/c‐MET.21